Johnson & Johnson Is Reporting Its Earnings on Tuesday. Here’s What To Expect.

The drug company’s legal battles, its pipeline of new treatments, and Washington’s efforts to rein in medical costs are key points to watch.

https://finance.yahoo.com/m/c0311e37...html?.tsrc=rss